The Pharmacokinetics of 4% Lidocaine Gel When Applied Topically to the Breasts

Completed · Phase 4

Conditions studied: Adverse Effects

In brief

The purpose of this study is to test the hypothesis that one-time application of 4% lidocaine gel (TOPICAINE) on the skin of the breasts and chest wall as recommended for pre-medication to reduce discomfort during screening mammography does not result in adverse effects, electrocardiogram (EKG) changes, or systemically toxic plasma concentration of lidocaine or its principal metabolite, monoethylglycinexylidide (MEGX).

Key facts

Study ID
NCT00925353
Run by
Mountain States Tumor and Medical Research Institute
People needed
13
Starts
2010-01-01
Expected to finish
2010-02-01
Last updated by the study team
2013-12-23

Who can join

Age: 35 and older. Sex: female. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.